-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas (ENXTPA:BNP) Could Be 2% Undervalued After Q2 Earnings And Interim Dividend

Simply Wall St·07/26/2026 03:27:15
語音播報

BNP Paribas (ENXTPA:BNP) has put income and earnings firmly in focus after the Board approved an interim dividend of €3.23 per share, alongside second quarter 2026 net income of €4,345 million.

See our latest analysis for BNP Paribas.

At a share price of €105.92, BNP Paribas has seen strong momentum build, with a 30 day share price return of 4.75% contributing to a 29.30% year to date share price gain and a 43.00% total shareholder return over the past year.

If this mix of income and price strength has your attention, it could be a good moment to broaden your watchlist with other ideas through the 108 top founder-led companies

After a strong run and a fresh interim dividend, the question for BNP Paribas is whether the current price already reflects this momentum, or if patience could offer a more attractive entry as the valuation picture comes into focus next.

Most Popular Narrative: 2.2% Undervalued

Based on the most followed narrative, BNP Paribas has a fair value of €108.27, sitting just above the latest close at €105.92, which keeps the focus firmly on what is driving that gap.

The integration of AXA IM and HSBC WM Germany, alongside ongoing expansion in high-growth markets (notably Turkey and Poland), is expected to significantly broaden BNP Paribas's distribution network and wealth management capabilities. This may directly increase fee-based revenue and support long-term earnings growth through enhanced client acquisition and cross-selling opportunities.

Read the complete narrative.

There is a full set of assumptions sitting behind that fair value, touching on future revenue, earnings, margins and the earnings multiple that might be justified. Want to see how those moving parts fit together and what would need to happen for BNP Paribas to earn that valuation label?

Result: Fair Value of €108.27 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still pressure points for BNP Paribas, including reliance on tightly regulated Eurozone markets, as well as ongoing cost and digital disruption challenges that could cap returns.

Find out about the key risks to this BNP Paribas narrative.

Another View On BNP Paribas Valuation

The fair value narrative points to BNP Paribas as about 2.2% undervalued, yet its 8.8x P/E tells a slightly different story. That multiple sits below the European Banks average at 12x and under the 9.5x fair ratio that the market could move towards. This points to a valuation gap that may reflect either mispricing or a simple quality and risk discount the market wants to keep in place.

To see how this ratio based view stacks up against other banks and what the fair ratio implies for potential re rating risk or room for further compression, See what the numbers say about this price — find out in our valuation breakdown.

ENXTPA:BNP P/E Ratio as at Jul 2026
ENXTPA:BNP P/E Ratio as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out BNP Paribas for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 245 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With both risks and rewards on the table for BNP Paribas, this is a moment to act quickly and review the full picture for yourself by weighing the 4 key rewards and 4 important warning signs

Looking for more investment ideas beyond BNP Paribas?

If you are already tracking BNP Paribas, now is the time to broaden your opportunity set and line up a few more candidates for your watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.